Grifols SA (GRLSbn.MC)
16.82EUR
22 Feb 2019
€-0.06 (-0.36%)
€16.88
€17.58
€17.58
€16.72
78,167
139,116
€21.30
€15.60
Latest Key Developments (Source: Significant Developments)
Grifols Receives FDA Approval For Procleix Babesia Assay For Donor Screening On Procleix Panther System
Feb 7 (Reuters) - Grifols SA
Grifols Starts Talks To Invest In Shanghai RAAS Blood Products
Nov 21 (Reuters) - Grifols
Grifols Approves Interim Dividend Of 0.20 Eur/Shr
Nov 2 (Reuters) - Grifols SA
Grifols Says AMBAR Results Show Reduction In Progression of Moderate Alzheimer's Disease
Oct 29 (Reuters) - Grifols SA
Grifols Reaches 25 Pct In Mecwins With Investment Of 2 Mln Euros
Oct 22 (Reuters) - Grifols SA
Grifols Disagrees With UBS Report On Potential Impact Of FcRn Inhibitors
Oct 3 (Reuters) - Grifols SA
Grifols Says FDA Approves New Gamastan To Treat Patients Exposed To Hepatitis A And Measles
Sept 4 (Reuters) - Grifols SA
Grifols H1 EBITDA Down 4.7 Pct At 614.2 Mln Euros YoY
July 27 (Reuters) - Grifols SA
Grifols To Pay Gross Dividend Of 0.204 Euro per Share
May 25 (Reuters) - Grifols SA
Grifols says FDA approves genetic test and EMA biological sealant
Nov 17 (Reuters) - GRIFOLS SA
Spanish stocks - Factors to watch on Friday
The following Spanish stocks may be affected by newspaper reports and other factors on Friday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: